Investor mix
10 investors on record; 4 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 30% |
| Private equity | 4 | 40% |
| Other / undisclosed | 3 | 30% |
Engineering microbes for in situ expression and secretion of novel biotherapeutic proteins and peptides.
10 investors on record; 4 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 30% |
| Private equity | 4 | 40% |
| Other / undisclosed | 3 | 30% |